MA5-15739 was used in western blotting to develop a 3D model for studying tumors by co-culturing HT-29 tumor spheroids with CCD-18co fibroblasts. Kim SA, Lee EK, Kuh HJ (2015) Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro. Exp Cell Res 335: 187–196.
MA5-15739 was used in western blotting to investigate the role of FoxO1 during adipocyte differentiation and adipogenesis. Zou P, Liu L, Zheng L et al. (2014) Targeting FoxO1 with AS1842856 suppresses adipogenesis. Cell Cycle 13: 3759–3767.
MA5-15739 was used in western blotting to study the control of excessive reactive astrogliosis and improved functional recovery in a rat model of spinal cord injury treated with an EGFR tyrosine kinase inhibitor. Li ZW, Li JJ, Wang L et al. (2014) Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. J Neuroinflammation 11: 71.
MA5-15739 was used in western blotting to investigate the mechanisms underlying dysregulated osteoclastogenesis in HIV. Lafferty MK, Fantry L, Bryant J et al. (2014) Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic rats. Pathog Dis 71: 81–89.
MA5-15739-HRP was used in western blotting to study the formation of amylin amyloid deposits in the cerebrovascular system and the implications for Alzheimer's disease. Jackson K, Barisone GA, Diaz E et al. (2013) Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann Neurol 74: 517–526.